Rang	Name	Position
1	Dr. Cheryl Renee Blanchard Ph.D.	Executive Chair
2	Mr. Stephen D. Griffin	President, Principal Financial Officer, CEO & Director
3	Mr. Ian W. McLeod	Senior VP, Chief Accounting Officer & Treasurer
4	Mr. Matthew Hall	Executive Director of Corporate Development & Investor Relations
5	Ms. Lisa Funiciello	VP & Chief Human Resources Officer
6	Mr. Ben Joseph	Senior Vice President of Commercial
7	Ms. Mira Leiwant	Senior Vice President of Regulatory, Quality & Clinical Affairs

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	BlackRock Inc	11,92%	33,27 Mio. USD
2	Caligan Partners LP	10,72%	29,94 Mio. USD
3	Morgan Stanley - Brokerage Accounts	6,52%	18,19 Mio. USD
4	Acadian Asset Management LLC	4,53%	12,65 Mio. USD
5	Vanguard Capital Management, LLC	4,53%	12,64 Mio. USD
6	BOOTHBAY FUND MANAGEMENT, LLC	3,96%	11,05 Mio. USD
7	Renaissance Technologies Corp	3,75%	10,48 Mio. USD
8	Dimensional Fund Advisors, Inc.	3,37%	9,41 Mio. USD
9	Capital Management Corp	3,35%	9,36 Mio. USD
10	Deutsche Bank AG	2,64%	7,37 Mio. USD
11	State Street Corp	2,59%	7,22 Mio. USD
12	Geode Capital Management, LLC	2,47%	6,89 Mio. USD
13	AQR Capital Management LLC	2,03%	5,68 Mio. USD
14	Jacobs Levy Equity Management, Inc.	1,98%	5,54 Mio. USD
15	Two Sigma Investments LLC	1,89%	5,28 Mio. USD
16	D. E. Shaw & Co LP	1,83%	5,11 Mio. USD
17	The Goldman Sachs Group Inc	1,63%	4,55 Mio. USD
18	Hillsdale Investment Management Inc.	1,04%	2,90 Mio. USD
19	UBS Group AG	0,99%	2,78 Mio. USD
20	Quantinno Capital Management LP	0,94%	2,63 Mio. USD